MRC
CME icon

Millburn Ridgefield Corp’s CME Group CME Stock Holding History

Millburn Ridgefield Corp’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-644
Closed -$142K – 87
2024
Q3 		$142K Sell
644
-86
-12% -$17.8K ﹤0.01% 81
2024
Q2 		$144K Buy
730
+20
+3% +$4.13K ﹤0.01% 57
2024
Q1 		$153K Buy
710
+2
+0.3% +$420 ﹤0.01% 55
2023
Q4 		$149K Sell
708
-112
-14% -$23.9K ﹤0.01% 64
2023
Q3 		$164K Sell
820
-418
-34% -$83.1K 0.01% 55
2023
Q2 		$229K Sell
1,238
-158
-11% -$29.2K 0.01% 67
2023
Q1 		$267K Sell
1,396
-221
-14% -$40K 0.01% 60
2022
Q4 		$272K Buy
1,617
+43
+3% +$7.47K 0.01% 55
2022
Q3 		$279K Sell
1,574
-295
-16% -$58.3K 0.01% 56
2022
Q2 		$383K Buy
1,869
+175
+10% +$37.1K 0.02% 52
2022
Q1 		$403K Buy
1,694
+1,000
+144% +$235K 0.02% 57
2021
Q4 		$159K Sell
694
-64
-8% -$14.1K 0.01% 61
2021
Q3 		$147K Sell
758
-5
-0.7% -$1.01K 0.01% 70
2021
Q2 		$162K Buy
+763
New +$161K 0.01% 75

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Millburn Ridgefield Corp's CME Position: Q4 2024 in Review

Millburn Ridgefield Corp sold out of CME Group (CME) in Q4 2024, closing a stake of 644 shares — an estimated $142K sold.

Millburn Ridgefield Corp first reported a position in CME in Q2 2021 and held it in 14 quarters. The position peaked at $403K in Q1 2022. 1,500 funds tracked by Wall St. Rank hold CME as of Q4 2024.

  • Millburn Ridgefield Corp reported no remaining CME Group position as of Q4 2024 after selling out during the quarter.
  • Millburn Ridgefield Corp sold 644 CME Group shares in Q4 2024, an estimated $142K.
  • Millburn Ridgefield Corp first reported a position in CME Group in Q2 2021 and held it in 14 quarters.
  • Millburn Ridgefield Corp's CME Group position peaked at $403K in Q1 2022.
  • 1,500 funds tracked by Wall St. Rank held CME Group as of Q4 2024.

Based on Millburn Ridgefield Corp's 13F filing for Q4 2024, filed 4 Feb 2025.